WHITNEY MCKINLEY: Open Payments
NPI 1861979965 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 60 payments from 29 companies in 2025. Trend: 2023 $559 · 2024 $433 · 2025 $1,108
Food & beverage: $1,108
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $186 |
| Merck Sharp & Dohme LLC | 7 | $129 |
| ABBVIE INC. | 4 | $70 |
| Janssen Biotech, Inc. | 3 | $62 |
| Incyte Corporation | 3 | $56 |
| BeOne Medicines USA, Inc. | 2 | $48 |
| Caris MPI, Inc. | 2 | $46 |
| Genentech USA, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
Products named: SCEMBLIX, KEYTRUDA, AYVAKIT, BRUKINSA, MI CANCER SEEK, JAKAFI, OPDIVO, VENCLEXTA.
Industry payments across MT — which companies pay providers there.
